Bausch Health Companies reported $0.78 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.78 0.71 0.61 Apr/29
FY2025Q4 Dec/2025 1.08 1.25 1.14 Feb/18
FY2025Q3 Sep/2025 1.16 1.1 1.14 Oct/29
FY2025Q2 Jun/2025 1.05 0.92 1.07 Jul/30
FY2025Q1 Mar/2025 0.61 0.82 0.63 Apr/30




Eps Change Date
Amgen USD 5.15 0.14 Mar/2026
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Aurora Cannabis CAD -0.64 0.36 Dec/2025
Bausch Health Companies USD 0.78 0.3 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Canopy Growth CAD -0.05 0.03 Dec/2025
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Danaher USD 2.06 0.17 Mar/2026
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novo Nordisk DKK 10.91 4.87 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026